PharmaCyte Biotech, Inc. (PMCB) Q2 2024 Earnings
PMCB·Reported August 13, 2024·Before market open
Diluted EPS came in at $-0.85.
Diluted EPS
$-0.85
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about PharmaCyte Biotech, Inc.'s Q2 2024 earnings report.
PharmaCyte Biotech, Inc. (PMCB) reported Q2 2024 earnings on August 13, 2024 before market open.
PharmaCyte Biotech, Inc. reported diluted EPS of $-0.85 for Q2 2024.